Skip to main content

Table 1 Average baseline of physiological metrics, 15-min prior to administration of intervention, ± represents SD

From: The effect of estrogen on brown adipose tissue activity in male rats

Route of administration

Treatment

Core temperature (°C)

iBAT temperature (°C)

Heart rate (bpm)

MAP (mmHg)

IP

Control

36.42 ± 0.20

34.71 ± 0.62

387 ± 27

133.00 ± 5.92

IP

Estrogen

36.50 ± 0.30

34.90 ± 1.23

426 ± 49

145.77 ± 9.14**

ICV

Control

36.60 ± 0.27

35.65 ± 0.72

394 ± 33

120.90 ± 15.24

ICV

Estrogen

36.37 ± 0.46

34.82 ± 0.69

427 ± 17*

160.27 ± 7.37***

  1. Statistical testing indicates some difference between estrogen and control conditions with the same routes of administration (IP or ICV) in cardiovascular baseline conditions prior to intervention. p-value calculated by unpaired, two-tailed t-test, n = 6 for IP-control; n = 7 for IP-estrogen and ICV-control; n = 8 for ICV-estrogen. *Indicates p < 0.05, **indicates p < 0.01, ***indicates p < 0.001. One rat was excluded from the IP-control group due to a procedural error. Two rats were excluded from the ICV-estrogen group due to prolonged (< 7 h) surgical complications experienced